A carregar...
How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?
Assessment of measurable residual disease, also called “minimal residual disease,” in patients with acute myeloid leukemia in morphological remission provides powerful prognostic information and complements pretreatment factors such as cytogenetics and genomic alterations. Based on data that low lev...
Na minha lista:
| Publicado no: | Haematologica |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ferrata Storti Foundation
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6669140/ https://ncbi.nlm.nih.gov/pubmed/31273094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.208454 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|